For the 90 million Americans with vision conditions, daily struggles can be compounded by barriers to proper care. So explains a new white paper from the Vision Health Advocacy Coalition, an organization dedicated to patient-centered vision care. As “Access to Treatment for Vision Conditions” explains, vision conditions can strike at any age and stem from genetics, injury, aging, infection and autoimmune diseases. They often interact with
As the “World report on vision” explains, 2.2 billion people live with a vision impairment. That’s 29% of the global population. And nearly half of those affected live with a condition that was preventable – or could be cured if properly addressed. Vision impairments can develop at any age, though many progress over time. Vision impairments can make it harder to master skills at every
After years without treatment options, people living with thyroid eye disease got a surprise from the FDA this week. Well before its anticipated March decision, the agency approved a first-of-its-kind medicine to treat the autoimmune disease. The drug, teprotumumab, is administered by infusion. Wiley Chambers, MD, of the FDA’s Center for Drug Evaluation and Research called the approval an “important milestone” for thyroid
